In the setting of recurrent breast cancer localized to the chest wall (no prior RT), do you allow concurrent abemaciclib or Enhertu with post-operative comprehensive chest wall irradiation?
1 Answers
Mednet Member
Radiation Oncology · Varian Medical Systems/Allegheny health network
We try to hold off as data on concurrent is very limited and in adjuvant studies, it was done sequentially.
In the setting of recurrent breast cancer localized to the chest wall (no prior RT), do you allow concurrent abemaciclib or Enhertu with post-operative comprehensive chest wall irradiation? | Mednet